Des(benzylpyridyl) Atazanavi
CAS No. 1192224-24-0
Des(benzylpyridyl) Atazanavi ( Des(benzylpyridyl) Atazanavir; FT-0665859; FT 0665859; FT0665859 )
Catalog No. M10665 CAS No. 1192224-24-0
Atazanavir is an highly potent HIV-1 protease inhibitor.
Purity : >98%(HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 35 | In Stock |
|
5MG | 43 | In Stock |
|
10MG | 61 | In Stock |
|
25MG | 138 | In Stock |
|
50MG | 235 | In Stock |
|
100MG | 422 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDes(benzylpyridyl) Atazanavi
-
NoteResearch use only, not for human use.
-
Brief DescriptionAtazanavir is an highly potent HIV-1 protease inhibitor.
-
DescriptionAtazanavir is an highly potent HIV-1 protease inhibitor.
-
SynonymsDes(benzylpyridyl) Atazanavir; FT-0665859; FT 0665859; FT0665859
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1 protease
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1192224-24-0
-
Formula Weight537.65
-
Molecular FormulaC26H43N5O7
-
Purity>98%(HPLC)
-
SolubilitySoluble in DMSO
-
SMILESO=C(OC)N[C@H](C(C)(C)C)C(NNC[C@H](O)[C@@H](NC([C@H](NC(OC)=O)C(C)(C)C)=O)CC1=CC=CC=C1)=O
-
Chemical NameMethyl N-[(2R)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2R)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gianotti N, et al. New Microbiol. 2007 Apr;30(2):79-88.
molnova catalog
related products
-
Ditiocarb sodium
Ditiocarb sodium (Sodium diethyldithiocarbamate) is an accelerator of the rate of copper cementation. Sodium diethyldithiocarbamate reduces the incidence of HIV infection.
-
YYA-021
A small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 9 uM against YTA48P virus with no significant cytotoxicity.
-
Diphyllin
Diphyllin could be characterized as a new V-ATPase inhibitor in treating gastric cancer and inhibiting the phosphorylation of LRP6 in Wnt/β-catenin signaling.